Ticker Details
Fulcrum Therapeutics, Inc.
IPO Date:	July 15, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$292.22M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.42 | 4.41%
Avg Daily Range (30 D):	$0.09 | 2.44%
Avg Daily Range (90 D):	$0.18 | 3.23%

Institutional Daily Volume
Avg Daily Volume:	.74M
Avg Daily Volume (30 D):	1.53M
Avg Daily Volume (90 D):	1.94M

Trade Size
Avg Trade Size (Sh.):	108
Avg Trade Size (Sh.) (30 D):	148
Avg Trade Size (Sh.) (90 D):	158

Institutional Trades
Total Institutional Trades:	945
Avg Institutional Trade:	$1.43M
Avg Institutional Trade (30 D):	$.8M
Avg Institutional Trade (90 D):	$1.1M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.48M
Avg Closing Trade (30 D):	$.84M
Avg Closing Trade (90 D):	$1.11M
Avg Closing Volume:	183.22K

News

Jun 2, 2026 @ 4:56 PM Fulcrum Therapeutics, Inc. Shareholders Are Encour... Source: Johnson Fistel, Pllp

Jun 2, 2026 @ 5:50 AM FULC Stock Crashes After Hours: What Investors Nee... Source: Tanya Rawat

Apr 27, 2026 @ 11:00 AM Fulcrum Therapeutics Announces Recent Business Hig... Source: Not Specified

Mar 19, 2026 @ 12:00 PM MedicAlert Foundation, Sickle Cell Disease Associa... Source: Na

Feb 24, 2026 @ 12:00 PM Fulcrum Therapeutics Announces Positive 12-Week Re... Source: Na

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS		$-.34	$-.25
Diluted EPS		$-.34	$-.25
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-26.18M	$-18.89M
Operating Income / Loss		$-29.31M	$-22.19M
Cost of Revenue
Net Cash Flow		$-1.9M	$-147.27M
PE Ratio